Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-07-21
1997-03-04
Schain, Howard E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 8, 514 15, 530395, 530396, 530412, 530413, 530427, 530840, 435183, 435207, A61K 3800, C07K 100, C12N 900
Patent
active
056079206
ABSTRACT:
The invention is directed to purified and isolated concanavalin A-binding proteins from chondrocytes that are not present in dedifferentiated cells from chondrocytes. The invention is also directed to a purified and isolated chondrocyte membrane protein, (CMP), which is a concanavalin A-binding protein, with a molecular weight of about 76 kD in SDS-PAGE. After treatment with endoglycosidase, CMP has an apparent molecular weight of about 67 kD. The N-terminal amino acid sequence and several internal amino acid sequences are given for CMP. These proteins can be used in assays, methods, or treatments involving differentiation of chondrocytes and the control of cartilaginous osteogenesis.
REFERENCES:
patent: 4919931 (1990-04-01), Rosenberg n ee G oldner
Yan et al, The Journal of Biological Chemistry, vol. 265, No. 17, pp. 10125-10131, Jun. 15, 1990.
Kato et al, Japanese Journal of Bone Metabolism, vol. 10, No. 2, pp. 187-192, 1992.
Kato et al, The Journal of Cell Biology, vol. 100, pp. 477-485, 1985.
Von der Mark et al, Chemical Abstracts, vol. 112, p. 269, Ref. #18590 h, 1990 (Ger. Offen. DE 3,721,790, Jan. 12, 1989).
Ben et al, Chemical Abstracts, vol. 110, p. 458, Ref. No. 112 181f, 1989 (Shika Kira Igakkai Zasshi 1988, 30(5) 703-6).
See et al, Biochem J, vol. 271, pp. 147-155, 1990.
Garratt et al.; A molecular model for the tumor-associated antigen, p. 97, suggests a Zn-binding function; FEBS Letters, vol. 305, No. 1 Jun. 1992; pp. 55-61.
Kato et al.; Sulfated Proteoglycan Synthesis by Confluent Cultures of Rabbit Costal Chondrocytes Grown in Presence of Fibroblast Growth Factor; The Journal of Cell Biology; vol. 100, 1985, pp. 477-485.
Yan et al.; Stimulation by Concanavalin A of Cartilage-Matrix Proteoglycan Synthesis in Chondrocyte Cultures; The Journal of Biological Chemistry; vol. 265, No. 17, Jun. 15, 1990, pp. 10125-10131.
Benya et al; Modulation of the Rabbit Chondrocyte Phenotype by Retinoic Acid Terminates Type II Collagen Synthesis Without Inducing Type I Collagen: The Modulated Phenotype Differs from that Produced by Subculture; Developmental Biology; vol. 118, 1986, pp. 296-305.
Kato et al.; Japanese Journal of Bone Metabolism; vol. 10, No. 2, 1992, pp. 187-192.
Doi Kazuyuki
Kato Yukio
Pan Haiou
Hoechst Japan Limited
Mohamed Abdel A.
Schain Howard E.
LandOfFree
Concanavalin a binding proteins and a 76kD chondrocyte membrane does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Concanavalin a binding proteins and a 76kD chondrocyte membrane , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Concanavalin a binding proteins and a 76kD chondrocyte membrane will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2146037